MENU
  • About Us
    • Profile
  • Blog
    • Comment Policy
  • Links
    • Category
    • Archive
  • For Media Inquiries
  • Contact Us
  • 日本語
  • English
Empowering Life Sciences for Blooming Life
Create the Most Advanced Therapeutics ~ Pharmas, Biotech Ventures, and Investors~
  • About Us
    • Profile
  • Blog
    • Comment Policy
  • Links
    • Category
    • Archive
  • For Media Inquiries
  • Contact Us
  • 日本語
  • English
  • About Us
  • Blog
  • Links
  • For Media Inquiries
  • Contact Us
  • 日本語
  • English
Create the Most Advanced Therapeutics ~ Pharmas, Biotech Ventures, and Investors~
  • About Us
    • Profile
  • Blog
    • Comment Policy
  • Links
    • Category
    • Archive
  • For Media Inquiries
  • Contact Us
  • 日本語
  • English
  1. Home
  2. 2025年
  3. February

February 2025– date –

  • Oncology FDA Approval

    Oncology Drug Approval News Flash: Vimseltinib (Romvimza) Approved by FDA for Tenosynovial Giant Cell Tumor (TGCT)

    【FDA Approval Alert】Deciphera's vimseltinib (Romvimza) Approved for TGCT (February 14, 2025) On February 14, 2025, the U.S. FDA approved vimseltinib (Romvimza) for adult patients with symptomatic tenosynovial giant cell tumor (TGCT) wh...
    2025-02-18
  • Oncology FDA Approval

    Oncology Drug Approval News Flash: Brentuximab Vedotin + Lenalidomide + Rituximab Combination Receives Accelerated FDA Approval for R/R LBCL

    【FDA Approval Alert】Seagen's brentuximab vedotin combination Approved for Relapsed/Refractory Large B-Cell Lymphoma (LBCL) (February 11, 2025) On February 11, 2025, the U.S. FDA granted accelerated approval to brentuximab vedotin (Adce...
    2025-02-12
  • Oncology FDA Approval

    Oncology Drug Approval News Flash: Mirdametinib (Gomekli) Approved by FDA for NF1-Associated Plexiform Neurofibromas

    【FDA Approval Alert】SpringWorks's mirdametinib (Gomekli) Approved for NF1-Associated Plexiform Neurofibromas (February 11, 2025) On February 11, 2025, the U.S. FDA approved mirdametinib (Gomekli) for patients aged 2 years and older wit...
    2025-02-12
1
  • Disclaimer
  • Privacy Policy
  • Sitemap
  • Contact Us
  • 日本語
  • English

© Create the Most Advanced Therapeutics ~ Pharmas, Biotech Ventures, and Investors~.

  • Menu
  • Disclaimer
  • Privacy Policy
  • Sitemap
  • Contact Us
  • 日本語
  • English